These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 22877147)

  • 1. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer stem cells by curcumin and clinical applications.
    Li Y; Zhang T
    Cancer Lett; 2014 May; 346(2):197-205. PubMed ID: 24463298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
    Yoshida GJ; Saya H
    Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation linking EMT and cancer stem cells.
    Zhou C; Liu J; Tang Y; Liang X
    Oral Oncol; 2012 Nov; 48(11):1068-75. PubMed ID: 22766510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
    Leal JA; Lleonart ME
    Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells: the development of new cancer therapeutics.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.
    Bao B; Azmi AS; Li Y; Ahmad A; Ali S; Banerjee S; Kong D; Sarkar FH
    Curr Stem Cell Res Ther; 2014 Jan; 9(1):22-35. PubMed ID: 23957937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.